One Grant, Three Products, a Million Opportunities

Kvantify was given an opportunity, we took it, and we nailed it!

Back in the summer of 2023 we were awarded €2.5 million in funding by the European Innovation Council (EIC) under one of the EU’s most competitive innovation schemes, the Accelerator program. Since then, our interdisciplinary team has worked tirelessly to advance quantum-enabled drug discovery by developing innovative technologies that harness the best of quantum computing and classical high-performance computing (HPC).

This high-stake venture has led to the development of a platform featuring proprietary algorithms designed to transform molecular discovery, reflecting deep insights from a variety of scientific disciplines. And we are exceedingly proud to look back on three successful product launches:

• Koffee – Binding Affinity Ranks small molecules by binding strength – balancing speed, accuracy, and simplicity.

• Koffee – Unbinding Kinetics Delivers physics-based residence time estimates in just 1–2 minutes per complex on a GPU.

• Kvantify Qrunch Enables non-quantum specialists to perform complex quantum chemistry calculations on real, state-of-the-art quantum hardware.

“With the support of the EIC Accelerator, we have turned bold ideas into market-ready technology and commercial opportunities, and we are offering a transformative solution which holds the potential to revolutionize pharmaceutical research and drug discovery,” says Nikolaj Thomas Zinner, co-founder and CSO of Kvantify.

The successful completion of the Accelerator project reflects Kvantify’s commitment to pioneering next-generation technologies and contributing to Europe’s leadership in quantum innovation. The grant has allowed us to establish a unique team of highly specialized and talented scientists who are on a joint mission to bring novel technological solutions to market.

At Kvantify we are constantly expanding our technologies, and we expect to announce exciting news in the coming weeks. So stay tuned!